Literature DB >> 6332137

T cell regulation of myelopoiesis: analysis at a clonal level.

J D Griffin, S C Meuer, S F Schlossman, E L Reinherz.   

Abstract

Colony-stimulating factor (CSF) production by a series of cloned human T lymphocyte cell lines was examined by substituting cloned T cells for peripheral blood mononuclear cells in the feeder layer of a double-layer agar CFU-C assay system. Of 12 T cell lines tested, all produced CSF when stimulated by specific antigen, whereas CSF production in the absence of stimulation was generally negligible. In the case of soluble antigen-specific (ragweed or tetanus toxoid) clones, this required both nominal antigen and the appropriate MHC gene product on autologous antigen-presenting cells, whereas in the case of clones specific for EBV-transformed B cell lines (allogeneic or autologous), surface-bound EBV-related antigen and MHC was necessary. When tested in this manner, CSF production by different cloned T cells was heterogeneous in both amount and subclass. Thus, although most clones stimulated growth of granulocyte, monocyte, and eosinophil colonies, certain clones were identified which preferentially stimulated some colony types but not others. This heterogeneity was particularly evident with respect to eosinophil colony production. In addition, a soluble inhibitor of granulocyte colony growth was produced by one clone. These findings provide further support for the notion that antigen-specific T cells may, on activation, regulate myelopoiesis in a precise way, and provide a possible cellular basis for selective eosinophilia, monocytosis, or neutrophilia seen in certain disease states.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6332137

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Peripheral blood and intrarenal phagocytic chemiluminescence during acute kidney graft rejection.

Authors:  F Schödel; F Krombach; C Hammer; W Brendel
Journal:  Inflammation       Date:  1986-09       Impact factor: 4.092

2.  The effects of eosinophil activating factor on IgG-dependent sulphidopeptide leukotriene generation by human eosinophils.

Authors:  P Fitzharris; R Moqbel; K J Thorne; B A Richardson; A Hartnell; O Cromwell; A E Butterworth; A B Kay
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

Review 3.  Eosinophils as effector cells in immunity and hypersensitivity disorders.

Authors:  A B Kay
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

4.  Cellular immunological defects of chronic myelogenous leukaemics: partial dependence on busulphan therapy.

Authors:  G Pawelec; H Schmidt; E Schneider; H J Bühring; G Ehninger
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

5.  Regulation of surface expression of the granulocyte/macrophage colony-stimulating factor receptor in normal human myeloid cells.

Authors:  S A Cannistra; P Groshek; R Garlick; J Miller; J D Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

6.  Human granulocyte-macrophage colony-stimulating factor induces expression of the tumor necrosis factor gene by the U937 cell line and by normal human monocytes.

Authors:  S A Cannistra; A Rambaldi; D R Spriggs; F Herrmann; D Kufe; J D Griffin
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

7.  Defective T-cell differentiation in acquired immune deficiency syndrome (AIDS).

Authors:  E M Levy; J C Beldekas; K H Mayer; P H Black
Journal:  J Clin Immunol       Date:  1986-03       Impact factor: 8.317

8.  Modulation of in vitro myelopoiesis by alloreactive T cell clones.

Authors:  F W Busch; P Wernet; P Meyer; E M Schneider; G Pawelec
Journal:  Blut       Date:  1986-05

9.  Interleukin 5 expressing allergen-specific T-lymphocytes in patients with house dust mite sensitization: analysis at a clonal level.

Authors:  R Bonifer; C Neumann; S Meuer; G Schulze; F Herrmann
Journal:  J Mol Med (Berl)       Date:  1995-02       Impact factor: 4.599

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.